Teclistamab in Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, +31

New England Journal of Medicine

Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri, +30

New England Journal of Medicine

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, +49

New England Journal of Medicine

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

María‐Victoria Mateos, Katja Weisel, Valerio De Stefano, +30

Leukemia

Relapsed/refractory MmCancer ManagementImmunologySurgeryPharmacotherapy +16

Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study

Peter Vandenberghe, Iwona Włodarska, Thomas Tousseyn, +12

The Lancet Haematology

Lymphoid NeoplasiaHodgkin/reed-sternberg CellsTumor HeterogeneityMedicineMalignant Blood Disorder +12

Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.

Nikhil C. Munshi, Larry D. Anderson, Nina Shah, +17

Journal of Clinical Oncology

ImmunologyImmune RegulationImmunoeditingImmunotherapeuticsCd4 T Cell Responses +20

HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM)

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt, +26

Blood

Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes

Michel Delforge, H Demuynck, Peter Vandenberghe, +6

Blood

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

T. de Witte, A Hagemeijer, Stefan Suciu, +17

Haematologica

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

Artur Jurczyszyn, Jakub Radocha, Julio Dávila, +31

British Journal of Haematology